Please wait a minute...
文章检索
预防医学  2022, Vol. 34 Issue (8): 842-847    DOI: 10.19485/j.cnki.issn2096-5087.2022.08.017
  疾病监测 本期目录 | 过刊浏览 | 高级检索 |
2021年浙江省法定传染病疫情分析
傅天颖, 吴昊澄, 鲁琴宝, 丁哲渊, 王心怡, 杨珂, 吴晨, 林君芬
浙江省疾病预防控制中心公共卫生监测与业务指导所,浙江 杭州 310051
Epidemiological characteristics of notifiable infectious diseasesin Zhejiang Province, 2021
FU Tianying, WU Haocheng, LU Qinbao, DING Zheyuan, WANG Xinyi, YANG Ke, WU Chen, LIN Junfen
Department of Public Health Surveillance and Advisory, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China
全文: PDF(880 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解2021年浙江省法定传染病疫情特征,为制定传染病防控措施提供依据。方法 通过中国疾病预防控制信息系统传染病监测系统收集2021年浙江省法定传染病报告资料,采用描述性流行病学方法分析浙江省2021年法定传染病的发病和死亡情况。结果 2021年浙江省共报告法定传染病29种,发病396 623例,报告发病率为614.28/10万;死亡391例,报告死亡率为0.605 6/10万。乙类传染病发病93 204例,报告发病率为144.35/10万;丙类传染病发病303 419例,报告发病率为469.92/10万;无甲类传染病报告。乙类传染病中,梅毒、肺结核、病毒性肝炎和淋病报告发病率较高,分别为39.45/10万、37.12/10万、31.90/10万和26.34/10万;艾滋病和肺结核报告死亡率较高,分别为0.477 0/10万和0.116 2/10万。丙类传染病中,手足口病、其他感染性腹泻和流行性感冒报告发病率较高,分别为192.00/10万、184.24/10万和86.45/10万。按不同传播途径分,肠道传染病和呼吸道传染病报告发病率较高,分别为384.10/10万和133.73/10万。乙类传染病报告发病率较高地区为舟山市和宁波市;丙类传染病报告发病率较高的地区为宁波市。浙江省新冠肺炎报告1 101例,其中确诊712例,无症状感染者389例,无死亡病例。结论 2021年浙江省法定传染病报告发病率较新冠肺炎疫情发生前有所下降,其中呼吸道传染病和肠道传染病下降明显。应在做好新冠肺炎防控的同时加强肺结核、病毒性肝炎和艾滋病防治,防范流行性感冒、手足口病和其他感染性腹泻的季节性流行。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
傅天颖
吴昊澄
鲁琴宝
丁哲渊
王心怡
杨珂
吴晨
林君芬
关键词 法定传染病流行特征传染病监测浙江省    
AbstractObjective To investigate the epidemiological features of notifiable infectious diseases in Zhejiang Province in 2021, so as to provide the evidence for formulating infectious disease control measures. Methods The data pertaining to notifiable infectious diseases reported in Zhejiang Province in 2021 were retrieved from the Infectious Disease Surveillance System of China Information System for Disease Control and Prevention. The incidence and mortality of notifiable infectious diseases in Zhejiang Province in 2021 were descriptively analyzed. Results Totally 29 types of notifiable infectious diseases with 396 623 cases and 391 deaths were reported in Zhejiang Province in 2021, with a reported incidence of 614.28/105 and a reported mortality of 0.605 6/105, respectively. There were 93 204 cases with class B notifiable infectious diseases, with a reported incidence rate of 144.35/105 and 303 419 cases with class C notifiable infectious diseases, with a reported incidence rate of 469.92/105; while no cases with class A notifiable infectious diseases were reported. Syphilis (39.45/105), tuberculosis (37.12/105), viral hepatitis (31.90/105) and gonorrhea (26.34/105) were the four most common class B notifiable infectious diseases, and AIDS (0.477 0/105) and pulmonary tuberculosis (0.116 2/105) were the two most deadly class B notifiable infectious diseases, while hand, foot and mouth disease (192.00/105), other infectious diarrhea (184.24/105) and influenza (86.45/105) were the three most common class C notifiable infectious diseases. According to the transmission route, intestinal and respiratory infectious diseases were the two most common infectious diseases, with reported incidence rates of 384.10/105 and 133.73/105, respectively; and according to the reported region, the highest incidence of class B notifiable infectious diseases was reported in Zhoushan and Ningbo cities, and the highest incidence of class C notifiable infectious diseases was reported in Ningbo City. Totally 1 101 COVID-19 cases were reported in Zhejiang Province in 2021, including 712 confirmed cases and 389 asymptomatic cases, and no deaths occurred. Conclusions The reported incidence of notifiable infectious diseases declined in Zhejiang Province in 2021 as compared to that prior to COVID-19 epidemics, with remarkable reductions in the incidence of respiratory and intestinal infectious diseases. The management of pulmonary tuberculosis, viral hepatitis and AIDS requires to be reinforced during the containment of COVID-19, to prevent the seasonable epidemic of influenza, hand, foot and mouth disease and other infectious diarrhea in Zhejiang Province.
Key wordsnotifiable infectious disease    epidemiological characteristics    infectious disease surveillance    Zhejiang Province
收稿日期: 2022-02-23      修回日期: 2022-06-27      出版日期: 2022-08-10
中图分类号:  R51  
基金资助:浙江省重点研发计划项目(2021C03038)
作者简介: 傅天颖,硕士,医师,主要从事疫情监测和传染病预防控制工作
通信作者: 林君芬,E-mail:jflin@cdc.zj.cn   
引用本文:   
傅天颖, 吴昊澄, 鲁琴宝, 丁哲渊, 王心怡, 杨珂, 吴晨, 林君芬. 2021年浙江省法定传染病疫情分析[J]. 预防医学, 2022, 34(8): 842-847.
FU Tianying, WU Haocheng, LU Qinbao, DING Zheyuan, WANG Xinyi, YANG Ke, WU Chen, LIN Junfen. Epidemiological characteristics of notifiable infectious diseasesin Zhejiang Province, 2021. Preventive Medicine, 2022, 34(8): 842-847.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2022.08.017      或      https://www.zjyfyxzz.com/CN/Y2022/V34/I8/842
[1] 陈珺芳,孙昼,温圆圆,等.1950—2018年浙江省杭州市甲乙类传染病疾病谱分析[J].疾病监测,2020,35(4):333-339.
CHEN J F,SUN Z,WEN Y Y,et al.Changes of class A and B communicable disease spectrum in Hangzhou,1950-2018[J].Dis Surveill,2020,35(4):333-339.
[2] 刘艳,金玫华,沈建勇,等.新型冠状病毒肺炎疫情防控措施对湖州市流行性感冒流行特征的影响[J].预防医学,2021,33(4):332-336.
LIU Y,JIN M H,SHEN J Y,et al.The influence of COVID-19 prevention and control measures on the epidemic of influenza in Huzhou[J].Prev Med,2021,33(4):332-336.
[3] 丁哲渊,吴昊澄,鲁琴宝,等.2020年浙江省法定传染病疫情分析[J].预防医学,2021,33(4):325-331.
DING Z Y,WU H C,LU Q B,et al.Epidemiological characteristics of the notifiable infectious diseases reported in Zhejiang Province,2020[J].Prev Med,2021,33(4):325-331.
[4] 中国卫生健康委员会.2021年全国法定传染病疫情概况[EB/OL].(2022-04-22)[2022-06-27].http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=4fd88a291d914abf8f7a91f6333567e1.
[5] 吴昊澄,林君芬,吴晨,等.2013年浙江省部分传染病报告率与真实发病水平分析[J].中国预防医学杂志,2015,16(3):187-190.
WU H C,LIN J F,WU C,et al.Analysis onthe reporting rate and the actual incidence of some contagious diseases in Zhejiang,2013[J].Chin Prev Med,2015,16(3):187-190.
[6] 贺晓新,高志东.从新型冠状病毒肺炎疫情看结核病防控策略与措施[J].首都公共卫生,2020,14(3):113-116.
HE X X,GAO Z D.Indication from coronavirus disease 2019 epidemic prevention and control for tuberculosis[J].Cap J Public Health,2020,14(3):113-116.
[7] 沈鑫,沙巍,刘剑君.新型冠状病毒肺炎疫情对结核病防控的影响及对策[J].中国防痨杂志,2020,42(6):544-548.
SHEN X,SHA W,LIU J J.Impact of coronavirus disease 2019(COVID-19)on tuberculosis control and countermeasures in China[J].Chin J Antitubercul,2020,42(6):544-548.
[8] 刘铁诚,何寒青,周洋,等.2005—2017年浙江省百日咳流行病学分析[J].中国疫苗和免疫,2019,25(1):54-58.
LIU T C,HE H Q,ZHOU Y,et al.Epidemiology of pertussis in Zhejiang province,2005-2017[J].Chin J Vaccines Immunization,2019,25(1):54-58.
[9] 王前,李涛,杜昕,等.2015—2019年全国肺结核报告发病情况分析[J].中国防痨杂志,2021,43(2):107-112.
WANG Q,LI T,DU X,et al.The analysis of national tuberculosis reported incidence and mortality,2015-2019[J].Chin J Antitubercul,2021,43(2):107-112.
[10] 孙印旗,王乐雨,曹玉雯,等.河北省2012—2018年百日咳病例医疗机构报告分析[J].中国疫苗和免疫,2019,25(6):655-659.
SUN Y Q,WANG L Y,CAO Y W,et al.Pertussis rates based on hospital reporting in Hebei province,2012-2018[J].Chin J Vaccines Immunization,2019,25(6):655-659.
[11] 李军,杨凯朝,赵东阳,等.2005—2019年河南省百日咳流行特征分析[J].河南预防医学杂志,2020,31(9):668-670,687.
LI J,YANG K C,ZHAO D Y,et al.Epidemiology of pertussis in Henan province in 2005-2019[J].Henan J Prev Med,2020,31(9):668-670,687.
[12] 谭慧仪,李纯颖,肖岚,等.湖南省2009—2018年百日咳流行特征分析与发病趋势预测[J].中华疾病控制杂志,2020,24(11):1263-1268,1281.
TAN H Y,LI C Y,XIAO L,et al.Epidemiological characteristics and trend prediction of pertussis in Hunan Province from 2009 to 2018[J].Chin J Dis Control Prev,2020,24(11):1263-1268,1281.
[13] 蔡路奎,李婧妍,姬秋彦,等.2004—2019年我国百日咳报告病例流行病学特征分析[J].预防医学情报杂志,2021,37(8):1036-1043.
CAI L K,LI J Y,JI Q Y,et al.Epidemiological characteristics of reported cases of pertussis in China from 2004 to 2019[J].J Prev Med Inf,2021,37(8):1036-1043.
[14] 宁桂军,高源,吴丹,等.中国2011—2017年百日咳流行病学特征分析[J].中国疫苗和免疫,2018,24(3):264-267,273.
NING G J,GAO Y,WU D,et al.Epidemiology of pertussis in China,2011-2017[J].Chin J Vaccines Immunization,2018,24(3):264-267,273.
[15] 姚强,曾凡荣,费丽娟,等.浙江省2010—2019年梅毒流行趋势分析[J].中华流行病学杂志,2020,41(8):1313-1318.
YAO Q,ZENG F R,FEI L J,et al.Epidemiology of syphilis in Zhejiang province,2010-2019[J].Chin J Epidemiol,2020,41(8):1313-1318.
[16] 周洋,何寒青,严睿,等.2005—2017年浙江省乙型肝炎流行病学特征[J].中国疫苗和免疫,2019,25(2):126-130.
ZHOU Y,HE H Q,YAN R,et al.Epidemiology of hepatitis B in Zhejiang province during 2005-2017[J].Chi J Vaccines Immunization,2019,25(2):126-130.
[17] WHITLOCK G G,MCOWAN A,NUGENT D.Gonorrhoea during COVID-19 in London,UK[J].Sex Transm Infect,2021,97(8):622-623.
[18] APALLA Z,LALLAS A,MASTRAFTSI S,et al.Impact of COVID-19 pandemic on STIs in Greece[J/OL].Sex Transm Infect,2022,98(1)[2022-06-27].http://dx.doi.org/10.1136/sextrans-2021-054965.
[19] CRANE M A,POPOVIC A,STOLBACH A I,et al.Reporting of sexually transmitted infections during the COVID-19 pandemic[J].Sex Transm Infect,2021,97(2):101-102.
[20] YAN X,WANG X,ZHANG X,et al.The epidemic of sexually transmitted diseases under the influence of COVID-19 in China[J/OL].Front Public Health,2021,9[2022-06-27].http://doi.org/10.3389/fpubh.2021.737817.
[21] SENTÍS A,PRATS-URIBE A,LÓPEZ-CORBETO E,et al.The impact of the COVID-19 pandemic on Sexually Transmitted Infections surveillance data:incidence drop or artefact?[J/OL].BMC Public Health,2021,21(1)[2022-06-27].http://doi.org/10.1186/s12889-021-11630-x.
[22] 王桢,凌锋,刘营,等.浙江省2015—2019年登革热流行特征分析[J].中国媒介生物学及控制杂志,2020,31(6):643-647.
WANG Z,LING F,LIU Y,et al.Epidemiological characteristics of dengue fever in Zhejiang province,China,2015-2019[J].Chin J Vector Biol Control,2020,31(6):643-647.
[23] 张轩,阮卫,陈华良,等.2017—2020年浙江省输入性疟疾疫情特征及病例诊断分析[J].中国血吸虫病防治杂志,2021,33(3):262-266,273.
ZHANG X,RUAN W,CHEN H L,et al.Epidemiological characteristics and diagnosis of imported malaria cases in Zhejiang Province from 2017 to 2020[J].Chin J Schistosomiasis Control,2021,33(3):262-266,273.
[24] 刘碧瑶,戚小华,江敏,等.浙江省境外输入新型冠状病毒肺炎病例流行特征分析[J].预防医学,2020,32(6):550-554.
LIU B Y,QI X H,JIANG M,et al.Epidemiological characteristics of imported COVID-19 cases from abroad to Zhejiang Province[J].Prev Med,2020,32(6):550-554.
[25] WEISS D J,BERTOZZI-VILLA A,RUMISHA S F,et al.Indirect effects of the COVID-19 pandemic on malaria intervention coverage,morbidity,and mortality in Africa:a geospatial modelling analysis[J].Lancet Infect Dis,2021,21(1):59-69.
[26] 王心怡,吴晨,缪梓萍,等.2021年3月浙江省突发公共卫生事件风险评估[J].预防医学,2021,33(3):217-220.
WANG X Y,WU C,MIAO Z P,et al.Risk assessment of public health emergencies in Zhejiang Province,March 2021[J].Prev Med,2021,33(3):217-220.
[1] 吕婧, 徐欣颖, 乔颖异, 石兴龙, 岳芳, 刘营, 程传龙, 张宇琦, 孙继民, 李秀君. 浙江省发热伴血小板减少综合征流行特征及影响因素分析[J]. 预防医学, 2026, 38(1): 10-14.
[2] 夏文玲, 高强, 李阳, 蔡奔, 万春雨, 崔志贞, 张正, 潘恩春. 2011—2024年淮安市发热伴血小板减少综合征流行特征和时空聚集性分析[J]. 预防医学, 2026, 38(1): 55-59,65.
[3] 方叶冬, 孙芳红, 邓建凯, 邱芳芳, 王晓臻, 周祖木. 瑞安市成年居民慢性病危险因素聚类分析[J]. 预防医学, 2026, 38(1): 60-65.
[4] 吴卉, 徐秋敏, 任治兴, 阴媛, 翟前前, 姚来顺. 2020—2024年长春市水痘流行特征和时空聚集性分析[J]. 预防医学, 2026, 38(1): 66-70,74.
[5] 凌红, 汪娜, 宋琴, 徐昊. 2009—2023年黄浦区肺结核流行特征和时空聚集性分析[J]. 预防医学, 2025, 37(9): 937-940.
[6] 张俊杰, 罗超, 姜立坤, 张慧颖. 2015—2024年哈尔滨市百日咳流行特征分析[J]. 预防医学, 2025, 37(9): 941-944.
[7] 魏志云, 罗小飞, 于颖洁, 贺亚琴, 杨倩, 窦强. 山西省布鲁氏菌病流行特征与空间聚集性分析[J]. 预防医学, 2025, 37(8): 842-845.
[8] 刘珊, 张劲松, 张文利, 王贺, 朱文烨, 沙琨. 猴痘病原学和流行病学研究进展[J]. 预防医学, 2025, 37(8): 789-793,798.
[9] 李克, 庞志峰, 吴晓虹, 王诚, 何瑶, 唐慧玲. 2007—2024年金华市钩端螺旋体病流行特征分析[J]. 预防医学, 2025, 37(8): 818-821.
[10] 李克, 庞志峰, 吴晓虹, 唐慧玲. 2005—2023年金华市猩红热流行特征和时空聚集性分析[J]. 预防医学, 2025, 37(7): 705-709.
[11] 刘艳, 张子喆, 王雨达, 刘光涛, 沈建勇. 2013—2023年湖州市手足口病流行特征[J]. 预防医学, 2025, 37(7): 718-721.
[12] 马莹, 张文霞, 马金宇, 董军强, 王秀琴, 李文玉, 赵立华. 2014—2023年宁夏流行性感冒时空聚集性分析[J]. 预防医学, 2025, 37(6): 608-611.
[13] 丁哲渊, 杨研, 傅天颖, 鲁琴宝, 王心怡, 吴昊澄, 刘魁, 林君芬, 吴晨. 2024年浙江省法定传染病疫情分析[J]. 预防医学, 2025, 37(5): 433-438,442.
[14] 周沁易, 马涛, 赵跃媛, 王恒学, 吴小清, 丁松宁, 苏晶晶. 2004—2022年南京市法定传染病发病趋势分析[J]. 预防医学, 2025, 37(5): 476-480.
[15] 张超, 沈建勇, 罗小福, 刘艳, 韩利萍. 2007—2023年湖州市流行性乙型脑炎流行特征[J]. 预防医学, 2025, 37(4): 386-389.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed